BioSpace News Archive

Press Releases

Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

July 16, 2024
·
5 min read
Press Releases

Celldex Therapeutics Initiates Global Phase 3 Program for Barzolvolimab in Patients with Chronic Spontaneous Urticaria

July 16, 2024
·
7 min read
Press Releases

Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma

July 16, 2024
·
7 min read
Press Releases

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

July 16, 2024
·
5 min read
News

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

July 16, 2024
·
7 min read
Business

BioXcel Therapeutics Announces Preliminary Estimated Unaudited Second Quarter Net Revenues from Sales of IGALMI™ (dexmedetomidine) Sublingual Film

July 16, 2024
·
13 min read
Drug Development

AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024

July 16, 2024
·
4 min read
Press Releases

T-Neuro Pharma Announces Publication of Groundbreaking Alzheimer’s Research in Prestigious Journal

July 16, 2024
·
2 min read
Business

Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis

July 16, 2024
·
2 min read
Press Releases

Recce Pharmaceuticals Receives $2 Million Grant from U.S. Department of Defense for RECCE® 327 Gel

July 16, 2024
·
4 min read